Kirk E. Fry
- Hepatology top 0.2%
- Infectious Diseases top 0.5%
- Molecular Biology top 10%
- Epidemiology top 5%
- Immunology top 5%
- Co-authors
- Gregory R. ReyesDaniel W. BradleyAlbert W. TamWinston SalserMatthew M. SmithMichael A. PurdyKa‐Cheung LukJames W. Larrick
- Topics
- Hepatitis Viruses Studies and Epidemiology (11 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)Viral gastroenteritis research and epidemiology (9 papers)
- Partner nations
- United StatesFranceCuba
In The Last Decade
Kirk E. Fry
43 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Hepatology 2.2k
- Infectious Diseases 1.8k
- Molecular Biology 761
- Epidemiology 590
- Immunology 561
Countries citing papers authored by Kirk E. Fry
This map shows the geographic impact of Kirk E. Fry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk E. Fry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk E. Fry more than expected).
Fields of papers citing papers by Kirk E. Fry
This network shows the impact of papers produced by Kirk E. Fry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk E. Fry. The network helps show where Kirk E. Fry may publish in the future.
Co-authorship network of co-authors of Kirk E. Fry
This figure shows the co-authorship network connecting the top 25 collaborators of Kirk E. Fry. A scholar is included among the top collaborators of Kirk E. Fry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk E. Fry. Kirk E. Fry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 314 | |
| 2 | 18 | |
| 3 | 17 | |
| 4 | 16 | |
| 5 | 15 | |
| 6 | 16 | |
| 7 | 173 | |
| 8 | 17 | |
| 9 | 280 | |
| 10 | 29 | |
| 11 | 47 | |
| 12 | Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genomebreakdown → | 868 |
| 13 | 34 | |
| 14 | 14 | |
| 15 | 16 | |
| 16 | 139 | |
| 17 | 18 | |
| 18 | 19 | |
| 19 | 1 | |
| 20 | 94 |
About Kirk E. Fry
Kirk E. Fry is a scholar working on Hepatology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 43 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatitis Viruses Studies and Epidemiology (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Viral gastroenteritis research and epidemiology (9 papers). The work is most often cited by research in Hepatology (2.2k citations), Infectious Diseases (1.8k citations) and Small Animals (381 citations). Kirk E. Fry has collaborated with scholars based in United States, France and Cuba. Frequent co-authors include Gregory R. Reyes, Daniel W. Bradley, Albert W. Tam, Winston Salser, Matthew M. Smith, Michael A. Purdy, Ka‐Cheung Luk, James W. Larrick, Patrice O. Yarbough and Douglas L. Brutlag. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.